世界の膣炎薬市場：専門的調査

• 英文タイトル：Global Vaginosis Drug Market Professional Survey Report 2019

• レポートコード：QYR9ST11767
• 出版社/出版日：QYResearch / 2019年9月10日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、114ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥518,000 (USD3,500)	▷ お問い合わせ
Enterprise License	￥1,036,000 (USD7,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※本調査レポートは、膣炎薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、Rx、OTCに、用途別には、病院、薬局、その他にセグメント区分し、膣炎薬の世界市場を分析しました。

・エグゼクティブ・サマリー
・膣炎薬の世界市場概要
・膣炎薬の製造コスト構成分析
・膣炎薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・膣炎薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・膣炎薬のセグメント分析（種類別）
（Rx、OTC）
・膣炎薬のセグメント分析（用途別）
（病院、薬局、その他）
・膣炎薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Bayer、Pfizer、Sanofi、Piramal、Abbott、Galderma、Mission、Alkem、Xiuzheng、Teva、Perrigo、West-Ward、HPGC、Yunnan Baiyao、Starpharma、Novel、Edenvridge）
・膣炎薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria.
The global Vaginosis Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Vaginosis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Vaginosis Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Vaginosis Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Vaginosis Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Bayer
Pfizer
Sanofi
Piramal
Abbott
Galderma
Mission
Alkem
Xiuzheng
Teva
Perrigo
West-Ward
HPGC
Yunnan Baiyao
Starpharma
Novel
Edenvridge

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Rx
OTC

Segment by Application
Hospital
Pharmacy
Other

レポート目次

Table of Contents

Executive Summary
1 Industry Overview of Vaginosis Drug
1.1 Definition of Vaginosis Drug
1.2 Vaginosis Drug Segment by Type
1.2.1 Global Vaginosis Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Rx
1.2.3 OTC
1.3 Vaginosis Drug Segment by Applications
1.3.1 Global Vaginosis Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Vaginosis Drug Overall Market
1.4.1 Global Vaginosis Drug Revenue (2014-2025)
1.4.2 Global Vaginosis Drug Production (2014-2025)
1.4.3 North America Vaginosis Drug Status and Prospect (2014-2025)
1.4.4 Europe Vaginosis Drug Status and Prospect (2014-2025)
1.4.5 China Vaginosis Drug Status and Prospect (2014-2025)
1.4.6 Japan Vaginosis Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Vaginosis Drug Status and Prospect (2014-2025)
1.4.8 India Vaginosis Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Vaginosis Drug
2.3 Manufacturing Process Analysis of Vaginosis Drug
2.4 Industry Chain Structure of Vaginosis Drug

3 Development and Manufacturing Plants Analysis of Vaginosis Drug
3.1 Capacity and Commercial Production Date
3.2 Global Vaginosis Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Vaginosis Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Vaginosis Drug Production and Capacity Analysis
4.2 Vaginosis Drug Revenue Analysis
4.3 Vaginosis Drug Price Analysis
4.4 Market Concentration Degree

5 Vaginosis Drug Regional Market Analysis
5.1 Vaginosis Drug Production by Regions
5.1.1 Global Vaginosis Drug Production by Regions
5.1.2 Global Vaginosis Drug Revenue by Regions
5.2 Vaginosis Drug Consumption by Regions
5.3 North America Vaginosis Drug Market Analysis
5.3.1 North America Vaginosis Drug Production
5.3.2 North America Vaginosis Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Vaginosis Drug Import and Export
5.4 Europe Vaginosis Drug Market Analysis
5.4.1 Europe Vaginosis Drug Production
5.4.2 Europe Vaginosis Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Vaginosis Drug Import and Export
5.5 China Vaginosis Drug Market Analysis
5.5.1 China Vaginosis Drug Production
5.5.2 China Vaginosis Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Vaginosis Drug Import and Export
5.6 Japan Vaginosis Drug Market Analysis
5.6.1 Japan Vaginosis Drug Production
5.6.2 Japan Vaginosis Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Vaginosis Drug Import and Export
5.7 Southeast Asia Vaginosis Drug Market Analysis
5.7.1 Southeast Asia Vaginosis Drug Production
5.7.2 Southeast Asia Vaginosis Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Vaginosis Drug Import and Export
5.8 India Vaginosis Drug Market Analysis
5.8.1 India Vaginosis Drug Production
5.8.2 India Vaginosis Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Vaginosis Drug Import and Export

6 Vaginosis Drug Segment Market Analysis (by Type)
6.1 Global Vaginosis Drug Production by Type
6.2 Global Vaginosis Drug Revenue by Type
6.3 Vaginosis Drug Price by Type

7 Vaginosis Drug Segment Market Analysis (by Application)
7.1 Global Vaginosis Drug Consumption by Application
7.2 Global Vaginosis Drug Consumption Market Share by Application (2014-2019)

8 Vaginosis Drug Major Manufacturers Analysis
8.1 Bayer
8.1.1 Bayer Vaginosis Drug Production Sites and Area Served
8.1.2 Bayer Product Introduction, Application and Specification
8.1.3 Bayer Vaginosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Pfizer
8.2.1 Pfizer Vaginosis Drug Production Sites and Area Served
8.2.2 Pfizer Product Introduction, Application and Specification
8.2.3 Pfizer Vaginosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Sanofi
8.3.1 Sanofi Vaginosis Drug Production Sites and Area Served
8.3.2 Sanofi Product Introduction, Application and Specification
8.3.3 Sanofi Vaginosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Piramal
8.4.1 Piramal Vaginosis Drug Production Sites and Area Served
8.4.2 Piramal Product Introduction, Application and Specification
8.4.3 Piramal Vaginosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Abbott
8.5.1 Abbott Vaginosis Drug Production Sites and Area Served
8.5.2 Abbott Product Introduction, Application and Specification
8.5.3 Abbott Vaginosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Galderma
8.6.1 Galderma Vaginosis Drug Production Sites and Area Served
8.6.2 Galderma Product Introduction, Application and Specification
8.6.3 Galderma Vaginosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Mission
8.7.1 Mission Vaginosis Drug Production Sites and Area Served
8.7.2 Mission Product Introduction, Application and Specification
8.7.3 Mission Vaginosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Alkem
8.8.1 Alkem Vaginosis Drug Production Sites and Area Served
8.8.2 Alkem Product Introduction, Application and Specification
8.8.3 Alkem Vaginosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Xiuzheng
8.9.1 Xiuzheng Vaginosis Drug Production Sites and Area Served
8.9.2 Xiuzheng Product Introduction, Application and Specification
8.9.3 Xiuzheng Vaginosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Teva
8.10.1 Teva Vaginosis Drug Production Sites and Area Served
8.10.2 Teva Product Introduction, Application and Specification
8.10.3 Teva Vaginosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Perrigo
8.12 West-Ward
8.13 HPGC
8.14 Yunnan Baiyao
8.15 Starpharma
8.16 Novel
8.17 Edenvridge

9 Development Trend of Analysis of Vaginosis Drug Market
9.1 Global Vaginosis Drug Market Trend Analysis
9.1.1 Global Vaginosis Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Vaginosis Drug Regional Market Trend
9.2.1 North America Vaginosis Drug Forecast 2019-2025
9.2.2 Europe Vaginosis Drug Forecast 2019-2025
9.2.3 China Vaginosis Drug Forecast 2019-2025
9.2.4 Japan Vaginosis Drug Forecast 2019-2025
9.2.5 Southeast Asia Vaginosis Drug Forecast 2019-2025
9.2.6 India Vaginosis Drug Forecast 2019-2025
9.3 Vaginosis Drug Market Trend (Product Type)
9.4 Vaginosis Drug Market Trend (Application)

10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Vaginosis Drug Distributors List
10.3 Vaginosis Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Vaginosis Drug
Table Global Vaginosis Drug Production (K Doses) Growth Rate Comparison by Types (2014-2025)
Figure Global Vaginosis Drug Production Market Share by Types in 2018
Figure Rx Product Picture
Figure OTC Product Picture
Table Global Vaginosis Drug Consumption (K Doses) Comparison by Applications (2014-2025)
Figure Global Vaginosis Drug Consumption Market Share by Applications in 2018
Figure Hospital
Figure Pharmacy
Figure Other
Figure Global Vaginosis Drug Revenue (Million USD) (2014-2025)
Figure Global Vaginosis Drug Production (K Doses) (2014-2025)
Figure North America Vaginosis Drug Market Size (Million USD) (2014-2025)
Figure Europe Vaginosis Drug Market Size (Million USD) (2014-2025)
Figure China Vaginosis Drug Market Size (Million USD) (2014-2025)
Figure Japan Vaginosis Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Vaginosis Drug Market Size (Million USD) (2014-2025)
Figure India Vaginosis Drug Market Size (Million USD) (2014-2025)
Table Vaginosis Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Vaginosis Drug in 2018
Figure Manufacturing Process Analysis of Vaginosis Drug
Figure Industry Chain Structure of Vaginosis Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Vaginosis Drug Manufacturing Plants Distribution
Table Vaginosis Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Vaginosis Drug Capacity (K Doses) of Major Manufacturers (2014-2019)
Table Vaginosis Drug Production (K Doses) of Major Manufacturers (2014-2019)
Table Vaginosis Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Vaginosis Drug Production Share by Manufacturers in 2018
Table Vaginosis Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Vaginosis Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Vaginosis Drug Revenue Share by Manufacturers in 2018
Table Vaginosis Drug Average Price (USD/Dose) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Vaginosis Drug Production by Regions 2014-2019 (K Doses)
Table Global Vaginosis Drug Production Market Share by Regions 2014-2019
Figure Global Vaginosis Drug Production Market Share by Regions in 2018
Table Global Vaginosis Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Vaginosis Drug Revenue Market Share by Regions 2014-2019
Figure Global Vaginosis Drug Revenue Market Share by Regions in 2018
Table Global Vaginosis Drug Consumption by Regions 2014-2019 (K Doses)
Table Global Vaginosis Drug Consumption Market Share by Regions 2014-2019
Figure North America Vaginosis Drug Production Growth Rate 2014-2019 (K Doses)
Figure North America Vaginosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Vaginosis Drug Production, Consumption Import and Export (K Doses)
Figure Europe Vaginosis Drug Production Growth Rate 2014-2019 (K Doses)
Figure Europe Vaginosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Vaginosis Drug Production, Consumption Import and Export (K Doses)
Figure China Vaginosis Drug Production Growth Rate 2014-2019 (K Doses)
Figure China Vaginosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Vaginosis Drug Production, Consumption Import and Export (K Doses)
Figure Japan Vaginosis Drug Production Growth Rate 2014-2019 (K Doses)
Figure Japan Vaginosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Vaginosis Drug Production, Consumption Import and Export (K Doses)
Figure Southeast Asia Vaginosis Drug Production Growth Rate 2014-2019 (K Doses)
Figure Southeast Asia Vaginosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Vaginosis Drug Production, Consumption Import and Export (K Doses)
Figure India Vaginosis Drug Production Growth Rate 2014-2019 (K Doses)
Figure India Vaginosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Vaginosis Drug Production, Consumption Import and Export (K Doses)
Figure Global Consumption Vaginosis Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Vaginosis Drug Market Share by Application (2014-2019)
Table Bayer Vaginosis Drug Production Sites and Area Served
Table Bayer Vaginosis Drug Product Introduction, Application and Specification
Table Bayer Vaginosis Drug Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Bayer Vaginosis Drug Production Growth Rate (2014-2019)
Table Bayer Vaginosis Drug Production Market Share (2014-2019)
Figure Bayer Vaginosis Drug Revenue Market Share (2014-2019)
Table Bayer Vaginosis Drug Main Business and Markets Served
Table Pfizer Vaginosis Drug Production Sites and Area Served
Table Pfizer Vaginosis Drug Product Introduction, Application and Specification
Table Pfizer Vaginosis Drug Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Pfizer Vaginosis Drug Production Growth Rate (2014-2019)
Table Pfizer Vaginosis Drug Production Market Share (2014-2019)
Figure Pfizer Vaginosis Drug Revenue Market Share (2014-2019)
Table Pfizer Vaginosis Drug Main Business and Markets Served
Table Sanofi Vaginosis Drug Production Sites and Area Served
Table Sanofi Vaginosis Drug Product Introduction, Application and Specification
Table Sanofi Vaginosis Drug Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Sanofi Vaginosis Drug Production Growth Rate (2014-2019)
Table Sanofi Vaginosis Drug Production Market Share (2014-2019)
Figure Sanofi Vaginosis Drug Revenue Market Share (2014-2019)
Table Sanofi Vaginosis Drug Main Business and Markets Served
Table Piramal Vaginosis Drug Production Sites and Area Served
Table Piramal Vaginosis Drug Product Introduction, Application and Specification
Table Piramal Vaginosis Drug Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Piramal Vaginosis Drug Production Growth Rate (2014-2019)
Table Piramal Vaginosis Drug Production Market Share (2014-2019)
Figure Piramal Vaginosis Drug Revenue Market Share (2014-2019)
Table Piramal Vaginosis Drug Main Business and Markets Served
Table Abbott Vaginosis Drug Production Sites and Area Served
Table Abbott Vaginosis Drug Product Introduction, Application and Specification
Table Abbott Vaginosis Drug Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Abbott Vaginosis Drug Production Growth Rate (2014-2019)
Table Abbott Vaginosis Drug Production Market Share (2014-2019)
Figure Abbott Vaginosis Drug Revenue Market Share (2014-2019)
Table Abbott Vaginosis Drug Main Business and Markets Served
Table Galderma Vaginosis Drug Production Sites and Area Served
Table Galderma Vaginosis Drug Product Introduction, Application and Specification
Table Galderma Vaginosis Drug Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Galderma Vaginosis Drug Production Growth Rate (2014-2019)
Table Galderma Vaginosis Drug Production Market Share (2014-2019)
Figure Galderma Vaginosis Drug Revenue Market Share (2014-2019)
Table Galderma Vaginosis Drug Main Business and Markets Served
Table Mission Vaginosis Drug Production Sites and Area Served
Table Mission Vaginosis Drug Product Introduction, Application and Specification
Table Mission Vaginosis Drug Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Mission Vaginosis Drug Production Growth Rate (2014-2019)
Table Mission Vaginosis Drug Production Market Share (2014-2019)
Figure Mission Vaginosis Drug Revenue Market Share (2014-2019)
Table Mission Vaginosis Drug Main Business and Markets Served
Table Alkem Vaginosis Drug Production Sites and Area Served
Table Alkem Vaginosis Drug Product Introduction, Application and Specification
Table Alkem Vaginosis Drug Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Alkem Vaginosis Drug Production Growth Rate (2014-2019)
Table Alkem Vaginosis Drug Production Market Share (2014-2019)
Figure Alkem Vaginosis Drug Revenue Market Share (2014-2019)
Table Alkem Vaginosis Drug Main Business and Markets Served
Table Xiuzheng Vaginosis Drug Production Sites and Area Served
Table Xiuzheng Vaginosis Drug Product Introduction, Application and Specification
Table Xiuzheng Vaginosis Drug Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Xiuzheng Vaginosis Drug Production Growth Rate (2014-2019)
Table Xiuzheng Vaginosis Drug Production Market Share (2014-2019)
Figure Xiuzheng Vaginosis Drug Revenue Market Share (2014-2019)
Table Xiuzheng Vaginosis Drug Main Business and Markets Served
Table Teva Vaginosis Drug Production Sites and Area Served
Table Teva Vaginosis Drug Product Introduction, Application and Specification
Table Teva Vaginosis Drug Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Teva Vaginosis Drug Production Growth Rate (2014-2019)
Table Teva Vaginosis Drug Production Market Share (2014-2019)
Figure Teva Vaginosis Drug Revenue Market Share (2014-2019)
Table Teva Vaginosis Drug Main Business and Markets Served
Table Perrigo Vaginosis Drug Production Sites and Area Served
Table West-Ward Vaginosis Drug Production Sites and Area Served
Table HPGC Vaginosis Drug Production Sites and Area Served
Table Yunnan Baiyao Vaginosis Drug Production Sites and Area Served
Table Starpharma Vaginosis Drug Production Sites and Area Served
Table Novel Vaginosis Drug Production Sites and Area Served
Table Edenvridge Vaginosis Drug Production Sites and Area Served
Figure Global Vaginosis Drug Production (K Doses) Growth Rate Forecast 2019-2025
Figure Global Vaginosis Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Vaginosis Drug Sales Price (USD/Dose) Forecast 2019-2025
Figure North America Vaginosis Drug Production Growth Rate Forecast 2019-2025 (K Doses)
Figure North America Vaginosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Vaginosis Drug Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Europe Vaginosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Vaginosis Drug Production Growth Rate Forecast 2019-2025 (K Doses)
Figure China Vaginosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Vaginosis Drug Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Japan Vaginosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Vaginosis Drug Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Southeast Asia Vaginosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Vaginosis Drug Production Growth Rate Forecast 2019-2025 (K Doses)
Figure India Vaginosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Doses) of Vaginosis Drug by Type (2019-2025)
Table Global Consumption (K Doses) of Vaginosis Drug by Application (2019-2025)
Table Vaginosis Drug Distributors List
Table Vaginosis Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

細菌性膣炎薬の世界市場：インサイト・予測

Global Bacterial Vaginosis Drugs Market Insights, Forecast to 2025
QYR9ST02296 2019年9月2日 114Pages
※本調査レポートでは、世界の細菌性膣炎薬市場について調査・分析し、以下の構成でお届け致します。細菌性膣炎薬の種類別には、経口、局所に、用途別には、骨盤内炎症性疾患、乳児早産、尿路感染、性感染症（STD）に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・ア...

アフィニトール薬の世界市場：インサイト・予測

Global Afinitor Drug Market Insights, Forecast to 2025
QYR9ST00769 2019年9月2日 114Pages
※本調査レポートでは、世界のアフィニトール薬市場について調査・分析し、以下の構成でお届け致します。アフィニトール薬の種類別には、2.5mg、5mg、7mg、10mgに、用途別には、病院、ドラッグストア、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中...

コセンティクス薬の世界市場：インサイト・予測

Global Cosentyx- Drug Market Insights, Forecast to 2025
QYR9ST00870 2019年9月2日 119Pages
※本調査レポートでは、世界のコセンティクス薬市場について調査・分析し、以下の構成でお届け致します。コセンティクス薬の種類別には、センソレディーペン、プレフィルドシリンジに、用途別には、病院、医薬品店に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリ...

レブリミド薬の世界市場：インサイト・予測

Global Revlimid Drug Market Insights, Forecast to 2025
QYR9ST02645 2019年9月2日 116Pages
※本調査レポートでは、世界のレブリミド薬市場について調査・分析し、以下の構成でお届け致します。レブリミド薬の種類別には、10mg、25mg、その他に、用途別には、病院、薬局、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセ...

レナリドミド薬の世界市場：インサイト・予測

Global Lenalidomide Drug Market Insights, Forecast to 2025
QYR9ST01044 2019年9月2日 119Pages
※本調査レポートでは、世界のレナリドミド薬市場について調査・分析し、以下の構成でお届け致します。レナリドミド薬の種類別には、5 mgカプセル、10 mgカプセル、15 mgカプセル、25 mgカプセルに、用途別には、多発性骨髄腫（MM）、骨髄異形成症候群（MDS）、その他に、地域別には、北米、アメリ...

世界のドルテグラビル・リルピビリン併用薬市場：専門的調査

Global Dolutegravir/Rilpivirine Combination Drug Market Professional Survey Report 2019
QYR9ST07554 2019年9月5日 106Pages
※本調査レポートは、ドルテグラビル・リルピビリン併用薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、自己生産API、APIのアウトソーシングに、用途別には、...

薬物乱用検査サービスの世界市場：市場規模・現状・予測

Global Drug of Abuse Testing Services Market Size, Status and Forecast 2019-2025
QYR9ST04814 2019年9月2日 92Pages
※当調査レポートでは、薬物乱用検査サービスの世界市場について調査・分析し、薬物乱用検査サービスの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（アルコール、大麻、コカイン、オピオイド、アンフェタミン、...

創薬アウトソーシングの世界市場：市場規模・現状・予測

Global Drug Discovery Outsourcing Market Size, Status and Forecast 2019-2025
QYR9ST05269 2019年9月2日 91Pages
※当調査レポートでは、創薬アウトソーシングの世界市場について調査・分析し、創薬アウトソーシングの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（小分子、生物製剤）、用途別（病院と診療所、医療研究所、そ...

創薬アウトソーシングの世界市場：市場規模・現状・予測

創薬の世界市場：市場規模・現状・予測

Global Drug Discovery Market Size, Status and Forecast 2019-2025
QYR9ST04813 2019年9月2日 90Pages
※当調査レポートでは、創薬の世界市場について調査・分析し、創薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（小分子薬、生物製剤）、用途別（研究所、製薬会社、バイオテクノロジー会社）、地域別（北米、...

細菌性膣炎薬の世界市場：インサイト・予測 Bacterial vaginosis is an imbalance of "good" and "bad" bacteria in the vagina, with there being more bad bacteria. Causes of an imbalance of bacteria can be caused by multiple sex partners and douching. Symptoms include odor, discharge, burning, and itching. Treatments for bacterial vaginosis inclu…
アフィニトール薬の世界市場：インサイト・予測 Everolimus is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an inhibitor of mammalian target of rapamycin (mTOR).The global Afinitor Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% duri…
レブリミド薬の世界市場：インサイト・予測 It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic treatment. Lenalidomide has also shown efficacy in the class of hematological disorders known as myelodysplastic syndromes (MDS).The global Revlimid Drug market is valued at xx million US$…
コセンティクス薬の世界市場：インサイト・予測 The global Cosentyx- Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cosentyx- Drug market based on company, product type, end…
レナリドミド薬の世界市場：インサイト・予測 It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic treatment. Lenalidomide has also shown efficacy in the class of hematological disorders known as myelodysplastic syndromes (MDS).The global Lenalidomide Drug market is valued at xx million…